Skip to Content

PharmaNutra SpA PHN

Morningstar Rating
€46.50 −4.20 (8.28%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHN is trading at a 511% premium.
Price
€50.62
Fair Value
€63.15
Uncertainty
High
1-Star Price
€87.65
5-Star Price
€67.73
Economic Moat
Flxynly
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHN is a good fit for your portfolio.

Trading Information

Previous Close Price
€50.70
Day Range
€46.3550.70
52-Week Range
€43.5563.50
Bid/Ask
€0.00 / €0.00
Market Cap
€447.10 Mil
Volume/Avg
24,115 / 5,453

Key Statistics

Price/Earnings (Normalized)
31.67
Price/Sales
4.85
Dividend Yield (Trailing)
1.83%
Dividend Yield (Forward)
1.83%
Total Yield
1.84%

Company Profile

PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia, and others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
105

Comparables

Valuation

Metric
PHN
ISP
AMP
Price/Earnings (Normalized)
31.678.7617.42
Price/Book Value
8.961.176.96
Price/Sales
4.852.503.39
Price/Cash Flow
29.156.3331.66
Price/Earnings
PHN
ISP
AMP

Financial Strength

Metric
PHN
ISP
AMP
Quick Ratio
1.770.41
Current Ratio
2.120.48
Interest Coverage
29.606.90
Quick Ratio
PHN
ISP
AMP

Profitability

Metric
PHN
ISP
AMP
Return on Assets (Normalized)
0.01%0.86%5.00%
Return on Equity (Normalized)
0.03%14.67%16.89%
Return on Invested Capital (Normalized)
0.51%9.87%
Return on Assets
PHN
ISP
AMP
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ANwvftkwmdZvy$77.1 Bil
MKKGY
Merck KGaA ADRQqqwkcbrbLszbx$74.3 Bil
HLN
Haleon PLC ADRFvgbvqrctSmcb$37.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRDhvsgxvksNrrv$18.3 Bil
VTRS
Viatris IncCtllxcskKdnf$13.5 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMbnbzrswKrmy$11.7 Bil
CTLT
Catalent IncTgdctdfsLhbwqf$10.0 Bil
CURLF
Curaleaf Holdings IncCylrqrdmfHhxzl$4.2 Bil
PRGO
Perrigo Co PLCGjkpnkgzHtdq$4.1 Bil
PBH
Prestige Consumer Healthcare IncQcxxrkqgHmgxzk$3.5 Bil

Sponsor Center